SEARCH

SEARCH BY CITATION

References

  • 1
    Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 9279.
  • 2
    Yarduminan DA, Mackie IJ, Machin SJ. Laboratory investigation of platelet function: a review of methodology. J Clin Pathol 1986; 39: 70112.
  • 3
    Pulcinelli FM, Riondino S. More on aspirin resistance: position paper of the Working Group on Aspirin Resistance. Proposal for a laboratory test guiding algorithm. J Thromb Haemost 2006; 4: 4857.
  • 4
    Breddin HK, Harder S. Usefulness of tests to measure platelet function. Vasa 2003; 32: 1239.
  • 5
    Moffat KA, Ledford-Kraemer MR, Nichols WL, Hayward CPM. Variability in clinical laboratory practice in testing for disorders of platelet function. Results of two surveys of the North American Specialized Coagulation Laboratory Asscociation. Thromb Haemost 2005; 93: 54953.
  • 6
    Breddin HK. Can platelet aggregometry be standardized? Platelets 2005; 16: 1518.
  • 7
    Mani H, Kirchmayr K, Kläffling C, Schindewolf M, Luxembourg B, Linnemann B, Lindhoff-Last E. Influence of blood collection techniques on platelet function. Platelets 2004; 15: 3158.
  • 8
    Gurbel PA, Tantry US. Clopidogrel resistance? Thromb Res 2007; 120: 31121.
  • 9
    Cattaneo M, Lecchi A, Zighetti ML, Lussana F. Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. Haematologica 2007; 92: 6947.
  • 10
    Labarthe B, Théroux P, Angioi M, Ghitescu M. Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. J Am Coll Cardiol 2005; 46: 63845.
  • 11
    Van Werkum JW, Kleibeuker M, Mieremet N, Ten Berg JM, Hackeng CM. Evaluation of the platelet response to clopidogrel with light transmittance aggregometry: peak aggregation or late aggregation? J Thromb Haemost 2007; 5: 8846.
  • 12
    Gachet C. Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 2006; 46: 277300.
  • 13
    Lordkipanidze M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007; 28: 17028.
  • 14
    Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerschal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US. Evaluation of dose-related effects of aspirin on platelet function. Results from the Aspirin-induced Platelet Effect (ASPECT) Study. Circulation 2007; 115: 315664.
  • 15
    Harrison P, Segal H, Blasbery K, Furtado C, Silver L, Rothwell PM. Screening for aspirin responsiveness after transient ischemic attack and stroke. Comparison of 2 point-of-care platelet function tests with optical aggregometry. Stroke 2005; 36: 10015.
  • 16
    Gum PA, Kottke-Marchant K, Poggio ED, Gurm H, Welsh PA, Brooks L, Sapp SK, Topol EJ. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001; 88: 2305.
  • 17
    Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003; 41: 9615.
  • 18
    Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, Hod H. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004; 109: 31715.
  • 19
    Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, Moschi G, Gori AM, Abbate R, Antoniucci D. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 2007; 49: 23127.